technetium-tc-99m-bicisate and Arterial-Occlusive-Diseases

Resting- and acetazolamide (Acz)-activated-regional cerebral blood flow (rCBF) measurements were performed by consecutive single-photon emission computed tomography (SPECT) studies before and after Acz administration using equal-volume-split technetium-99m-L,L-ethyl cysteinate dimer. Quantitative rCBF images were converted from qualitative axial SPECT images by the application of Patlak plot graphical analysis with radionuclide angiography and Lassen's linearization correction. Total time span required for this study was 53 minutes. The unaffected side of 37 studies with unilateral vascular lesions and 45 studies without apparent vascular lesions showed 132 +/- 17% and 140 +/- 15% increase of mean CBF (mCBF), respectively, under Acz administration. Comparing these values, the Acz-activated rCBF increases of less-affected and affected hemispheres of 23 studies with bilateral vascular lesions (116 +/- 13% and 113 +/- 12%, respectively) was lower with high statistical significance (P < 0.001). For the other 20 cases, physiologic saline was administered instead of Acz. This group showed no changes in mCBF under placebo administration (after placebo/baseline; 100 +/- 6%). Acetazolamide-activated rCBF increase was recognized clearly and easily using quantitative images. This noninvasive method is easy to perform and may be helpful to detect regional abnormalities of hemodynamic reserve in cerebrovascular diseases.

Topics: Acetazolamide; Adult; Aged; Arterial Occlusive Diseases; Carotid Stenosis; Cerebral Arterial Diseases; Cerebrovascular Circulation; Child; Circle of Willis; Cysteine; Female; Humans; Male; Middle Aged; Organotechnetium Compounds; Placebos; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon

Misery perfusion is defined as marginally sufficient cerebral blood supply relative to cerebral metabolic demand. The aim of the present study was to determine the optimal brain Tc-ethyl cysteinate dimer (ECD) SPECT imaging and analysis to detect misery perfusion on O PET imaging in patients with chronic occlusive disease of unilateral internal carotid or middle cerebral artery (MCA).. For 97 patients, cerebral blood flow, cerebral metabolic rate of oxygen, and oxygen extraction fraction were measured using O PET; Tc-ECD SPECT was performed using dynamic scanning with a scan duration of 10 minutes each for 50 minutes after tracer administration. A region of interest was placed in the bilateral MCA territories and in the bilateral cerebellar hemispheres in all standardized images using a 3-dimensional stereotaxic region-of-interest template and affected-to-contralateral asymmetry ratio in the MCA territory (ARMCA) and contralateral-to-affected asymmetry ratio in the cerebellar hemisphere (ARcbl) were calculated.. The ARMCA or ARcbl on Tc-ECD SPECT with a scan time of 20 to 30 minutes after tracer administration (ARMCA20-30 or ARcbl20-30) was correlated with ARMCA on PET cerebral blood flow (r = 0.654) or ARMCA on PET cerebral metabolic rate of oxygen (r = 0.576), respectively, more strongly than with other scan times. The area under the receiver operating characteristic curve for detecting abnormally elevated ARMCA on PET oxygen extraction fraction was significantly greater for ARcbl20-30/ARMCA20-30 (0.947) than for ARMCA20-30 alone (0.780) (difference between areas, 0.167; P = 0.0001) on Tc-ECD SPECT.. Combination of asymmetries in the cerebellar and cerebral hemispheres on Tc-ECD SPECT in a scan time of 20 to 30 minutes after tracer administration optimally detects misery perfusion in unilateral internal carotid artery or MCA occlusive disease.

Topics: Adult; Aged; Arterial Occlusive Diseases; Brain; Cerebral Arterial Diseases; Cerebrovascular Circulation; Chronic Disease; Cysteine; Female; Humans; Male; Middle Aged; Organotechnetium Compounds; Oxygen Radioisotopes; Positron-Emission Tomography; Tomography, Emission-Computed, Single-Photon

The purpose of this study was to evaluate the usefulness of SPECT during temporary carotid balloon occlusion testing and to evaluate the changes in regional cerebral blood flow (CBF) and regional cerebral perfusion reserve (CPR) after permanent carotid occlusion.. Temporary balloon occlusion testing was performed on 40 patients (24 head and neck tumors, 16 aneurysms). During the balloon occlusion (total time, 30 min), (99m)Tc-ethylcysteinate dimer (ECD) was injected intravenously about 5 min before balloon deflation, followed by SPECT data acquisition. SPECT images were visually evaluated, and the severity of hypoperfusion on the occluded side was classified using 4 grades (normal, mild, moderate, and severe). The count ratio of the occluded side to the contralateral side (L/N ratio) was also analyzed. In 7 patients who subsequently underwent permanent carotid occlusion, CBF and CPR were quantitatively assessed using (133)Xe inhalation dynamic SPECT at rest and after acetazolamide (ACZ) enhancement (CPR was defined as the percentage increase in CBF after ACZ), and the patients were followed up periodically.. SPECT after temporary occlusion showed moderate or severe hypoperfusion in 12 patients, whereas neurologic deterioration was observed in only 4 patients. The L/N ratios were 0.96 +/- 0.03 in normal perfusion (13 patients), 0.93 +/- 0.03 in mild hypoperfusion (15 patients), 0.83 +/- 0.03 in moderate hypoperfusion (10 patients) and 0.66 +/- 0.09 in severe hypoperfusion (2 patients) (P < 0.0001). In the 7 patients who underwent permanent carotid occlusion, CPR decreased after surgery (35% +/- 7% vs. 7% +/- 14%, P < 0.05), even though the resting CBF did not change (54 +/- 8 mL/100 g/min vs. 52 +/- 6 mL/100 g/min, not statistically significant). The steal phenomenon (rCPR < 0%) was observed in 3 patients, 1 of whom experienced transient hemiparesis when blood pressure dropped soon after surgery. On follow-up, the decreased CPR gradually improved and no infarction developed.. SPECT is useful to detect cerebral hypoperfusion during carotid occlusion. Assessment of CPR is recommended to predict the potential risk of postsurgical complications and to follow up patients after permanent carotid occlusion.

Topics: Adult; Aged; Arterial Occlusive Diseases; Balloon Occlusion; Brain; Carotid Artery Diseases; Cerebrovascular Circulation; Cysteine; Female; Humans; Male; Middle Aged; Organotechnetium Compounds; Tomography, Emission-Computed, Single-Photon

The brain distribution of 9mTc-hexamethylpropyleneamine oxime (HMPAO) correlates with regional brain perfusion, whereas 99mTc-ethyl cysteinate dimer (ECD) reflects not only perfusion but also the metabolic status of brain tissue. We compared 99mTc-ECD single-photon emission CT (SPECT) with 99mTc-HMPAO SPECT early after recanalization by local intraarterial thrombolysis (LIT) in patients with acute embolic middle cerebral artery occlusion. We also assessed the predictive value of 99mTc-HMPAO and 99mTc-ECD SPECT for the development of ischemic brain damage.. 99mTc-HMPAO and consecutive 99mTc-ECD SPECT studies were performed in 15 patients within 3 hours of LIT. The two SPECT studies were obtained independently using a subtraction technique. SPECT evaluation was performed using semiquantitative region-of-interest analysis. Noninfarction, infarction, and hemorrhage were identified by follow-up CT or MR imaging.. Forty-five lesions were identified (21 noninfarctions, 19 infarctions, and five hemorrhages). Regardless of 99mTc-HMPAO SPECT findings, lesions showing isoactivity (count rate densities of 0.9 to 1.1 as compared with the contralateral side) on 99mTc-ECD SPECT were salvaged. Lesions with hypoactivity (values < 0.9) on 99mTc-ECD SPECT developed irreversible brain damage. Hemorrhage appeared in lesions with both hyperactivity (values > 1.1) on 99mTc-HMPAO SPECT and hypoactivity on 99mTc-ECD SPECT.. The brain distribution of 99mTc-ECD in a reperfused area identified by 99mTc-HMPAO SPECT early after recanalization of acute ischemic stroke is dependent on cerebral tissue viability. By combining 99mTc-ECD and 99mTc-HMPAO SPECT, performed within the first few hours of LIT, it is possible to identify patients at risk for hemorrhagic transformation reliably.

Topics: Aged; Arterial Occlusive Diseases; Brain; Cerebral Hemorrhage; Cerebral Infarction; Cysteine; Female; Fibrinolytic Agents; Humans; Injections, Intra-Arterial; Intracranial Embolism; Magnetic Resonance Imaging; Male; Middle Aged; Organotechnetium Compounds; Predictive Value of Tests; Radiopharmaceuticals; Technetium Tc 99m Exametazime; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed

We evaluated 99Tcm-N,N'-(1,2-ethylenediyl)bis-L-cysteine diethyl ester (99Tcm-ECD) dynamic and static SPET (single photon emission tomographic) images to examine 99Tcm-ECD kinetics under ischaemic cerebrovascular conditions. In 20 patients who showed arterial occlusion on magnetic resonance angiography, dynamic (0-10 min) and static (15-35 min) SPET images were acquired after the intravenous administration of 99Tcm-ECD. Thirteen of the patients had focal perfusion deficits that were more evident on the dynamic than on the static images; the other seven showed no such discrepancy. In those patients with a mismatch between the dynamic and static images, the extent corresponded to reduced vaso-reactivity to acetazolamide. Based on quantitative analysis of the ratio of tracer uptake in affected to that in unaffected areas, the patients with discrepant findings showed significantly different ratios on the dynamic and static images, whereas those with no such mismatch did not. Our results suggest that dynamic 99Tcm-ECD images provide circulatory information and that static images reflect a filling-in phenomenon of ECD metabolites in ischaemic lesions. 99Tcm-ECD dynamic and static SPET images offer an alternative method of detecting mild perfusion deficits without the need for acetazolamide challenge.

Topics: Acetazolamide; Aged; Aged, 80 and over; Arterial Occlusive Diseases; Brain; Brain Ischemia; Carotid Stenosis; Cerebrovascular Circulation; Cysteine; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Organotechnetium Compounds; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon